These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 26878132)

  • 21. Human platelets as a substrate source for the in vitro amplification of the abnormal prion protein (PrP) associated with variant Creutzfeldt-Jakob disease.
    Jones M; Peden AH; Yull H; Wight D; Bishop MT; Prowse CV; Turner ML; Ironside JW; MacGregor IR; Head MW
    Transfusion; 2009 Feb; 49(2):376-84. PubMed ID: 18980616
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Distribution of Prion Protein Allotypes Differs Between Sporadic and Iatrogenic Creutzfeldt-Jakob Disease Patients.
    Moore RA; Head MW; Ironside JW; Ritchie DL; Zanusso G; Choi YP; Priola SA
    PLoS Pathog; 2016 Feb; 12(2):e1005416. PubMed ID: 26840342
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protease-sensitive conformers in broad spectrum of distinct PrPSc structures in sporadic Creutzfeldt-Jakob disease are indicator of progression rate.
    Kim C; Haldiman T; Cohen Y; Chen W; Blevins J; Sy MS; Cohen M; Safar JG
    PLoS Pathog; 2011 Sep; 7(9):e1002242. PubMed ID: 21931554
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of prion protein genotype and scrapie prion protein type with cellular prion protein charge isoform profiles in cerebrospinal fluid of humans with sporadic or familial prion diseases.
    Schmitz M; Lüllmann K; Zafar S; Ebert E; Wohlhage M; Oikonomou P; Schlomm M; Mitrova E; Beekes M; Zerr I
    Neurobiol Aging; 2014 May; 35(5):1177-88. PubMed ID: 24360565
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human prion protein (PrP) 219K is converted to PrPSc but shows heterozygous inhibition in variant Creutzfeldt-Jakob disease infection.
    Hizume M; Kobayashi A; Teruya K; Ohashi H; Ironside JW; Mohri S; Kitamoto T
    J Biol Chem; 2009 Feb; 284(6):3603-9. PubMed ID: 19074151
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Defining sporadic Creutzfeldt-Jakob disease strains and their transmission properties.
    Bishop MT; Will RG; Manson JC
    Proc Natl Acad Sci U S A; 2010 Jun; 107(26):12005-10. PubMed ID: 20547859
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Creutzfeldt-Jakob disease.
    Sikorska B; Knight R; Ironside JW; Liberski PP
    Adv Exp Med Biol; 2012; 724():76-90. PubMed ID: 22411235
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical features and diagnosis of dura mater graft associated Creutzfeldt Jakob disease.
    Noguchi-Shinohara M; Hamaguchi T; Kitamoto T; Sato T; Nakamura Y; Mizusawa H; Yamada M
    Neurology; 2007 Jul; 69(4):360-7. PubMed ID: 17646628
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Distinct pathological phenotypes of Creutzfeldt-Jakob disease in recipients of prion-contaminated growth hormone.
    Cali I; Miller CJ; Parisi JE; Geschwind MD; Gambetti P; Schonberger LB
    Acta Neuropathol Commun; 2015 Jun; 3():37. PubMed ID: 26108478
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of human PrPSc type and PRNP genotype in an in-vitro conversion assay.
    Jones M; Peden AH; Wight D; Prowse C; Macgregor I; Manson J; Turner M; Ironside JW; Head MW
    Neuroreport; 2008 Dec; 19(18):1783-6. PubMed ID: 18955905
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MRI characteristics of sporadic CJD with valine homozygosity at codon 129 of the prion protein gene and PrPSc type 2 in Japan.
    Fukushima R; Shiga Y; Nakamura M; Fujimori J; Kitamoto T; Yoshida Y
    J Neurol Neurosurg Psychiatry; 2004 Mar; 75(3):485-7. PubMed ID: 14966171
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Defining the phenotypic spectrum of sporadic Creutzfeldt-Jakob disease MV2K: the kuru plaque type.
    Baiardi S; Mammana A; Dellavalle S; Rossi M; Redaelli V; Colaizzo E; Di Fede G; Ladogana A; Capellari S; Parchi P
    Brain; 2023 Aug; 146(8):3289-3300. PubMed ID: 36883639
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Creutzfeldt-Jakob disease, prion protein gene codon 129VV, and a novel PrPSc type in a young British woman.
    Mead S; Joiner S; Desbruslais M; Beck JA; O'Donoghue M; Lantos P; Wadsworth JD; Collinge J
    Arch Neurol; 2007 Dec; 64(12):1780-4. PubMed ID: 18071044
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diffusion-weighted magnetic resonance imaging in dura mater graft-associated Creutzfeldt-Jakob disease.
    Sakai K; Hamaguchi T; Sanjo N; Murai H; Iwasaki Y; Hamano T; Honma M; Noguchi-Shinohara M; Nozaki I; Nakamura Y; Kitamoto T; Harada M; Mizusawa H; Yamada M
    J Neurol Sci; 2020 Nov; 418():117094. PubMed ID: 32823134
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Two distinct conformers of PrP
    Cali I; Espinosa JC; Nemani SK; Marin-Moreno A; Camacho MV; Aslam R; Kitamoto T; Appleby BS; Torres JM; Gambetti P
    Acta Neuropathol Commun; 2021 Mar; 9(1):55. PubMed ID: 33766126
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Autopsied case of non-plaque-type dura mater graft-associated Creutzfeldt-Jakob disease presenting with extensive amyloid-β deposition.
    Iwasaki Y; Imamura K; Iwai K; Kobayashi Y; Akagi A; Mimuro M; Miyahara H; Kitamoto T; Yoshida M
    Neuropathology; 2018 Oct; 38(5):549-556. PubMed ID: 30084170
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Creutzfeldt-Jakob disease (CJD) with a mutation at codon 148 of prion protein gene: relationship with sporadic CJD.
    Pastore M; Chin SS; Bell KL; Dong Z; Yang Q; Yang L; Yuan J; Chen SG; Gambetti P; Zou WQ
    Am J Pathol; 2005 Dec; 167(6):1729-38. PubMed ID: 16314483
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Panencephalopathic Creutzfeldt-Jakob disease with distinct pattern of prion protein deposition in a patient with D178N mutation and homozygosity for valine at codon 129 of the prion protein Gene.
    Marcon G; Indaco A; Di Fede G; Suardi S; Finato N; Moretti V; Micoli S; Fociani P; Zerbi P; Pincherle A; Redaelli V; Tagliavini F; Giaccone G
    Brain Pathol; 2014 Mar; 24(2):148-51. PubMed ID: 24118545
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Iatrogenic CJD due to pituitary-derived growth hormone with genetically determined incubation times of up to 40 years.
    Rudge P; Jaunmuktane Z; Adlard P; Bjurstrom N; Caine D; Lowe J; Norsworthy P; Hummerich H; Druyeh R; Wadsworth JD; Brandner S; Hyare H; Mead S; Collinge J
    Brain; 2015 Nov; 138(Pt 11):3386-99. PubMed ID: 26268531
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Deciphering the pathogenesis of sporadic Creutzfeldt-Jakob disease with codon 129 M/V and type 2 abnormal prion protein.
    Kobayashi A; Iwasaki Y; Otsuka H; Yamada M; Yoshida M; Matsuura Y; Mohri S; Kitamoto T
    Acta Neuropathol Commun; 2013 Nov; 1():74. PubMed ID: 24252157
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.